Successful small-incision lenticule extraction for myopia

Article

Small-incision lenticule extraction for moderate to high myopia provides high rates of patient satisfaction, refractive predictability and is a safe procedure.

Small-incision lenticule extraction for moderate to high myopia provides high rates of patient satisfaction, refractive predictability and is a safe procedure.

Dr Anders Vestergaard et al., Department of Ophthalmology, Aarhus University Hospital, Aarhus, Denmark, conducted a prospective clinical study on 144 patients with moderate to high myopia.

Small-incision lenticule extraction was performed with a femtosecond laser and manually extracted without flap creation. Each patient was treated and assessed for three months. One randomly selected eye of each patient was used for the statistical analyses.

Mean preoperative spherical equivalent was −7.18 D ± 1.57. In 40% of eyes with emmetropia as target refraction the uncorrected distance visual acuity was 0.1 logMAR or less one day postoperatively. This increased to 73% at three months postoperatively.

Mean corrected distance visual acuity (CDVA) significantly improved from -0.01 preoperatively to -0.03 three months postoperatively. Of the eyes studied, six lost one line of CDVA after three months and none of the eyes lost two lines or more of CDVA.

Achieved mean refraction was −0.09 ± 0.45 D from the attempted refraction. Out of the eyes included, 77% were within ±0.50 D and 95% were within ±1.00 D. As for patient satisfaction, 95% of the patients recommended the procedure to others.

To view the abstract visit the

Journal of Cataract and Refractive Surgery.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.